The Effect of Alpha-lactalbumin on Microbiota Composition
NCT ID: NCT05674318
Last Updated: 2024-02-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
10 participants
INTERVENTIONAL
2023-01-30
2023-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Dietary Supplement With and Without a Probiotic and/or Antibiotic
NCT05141903
Combination of Probiotic and Calcium in Healthy Adults
NCT01033461
Metabolomic Effects of Probiotics Administration
NCT04506385
Effect of Probiotic Formula on Reducing the Risk for Antibiotic-associated Diarrhoea
NCT01596829
To Investigate the Effect of Arabinogalactan on the Gut Microbiome in Adults
NCT04351841
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Alpha-lactalbumin
Alpha-lactalbumin
Oral assumption of two tabs/day containing Alpha-lactalbumin for 30 days
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Alpha-lactalbumin
Oral assumption of two tabs/day containing Alpha-lactalbumin for 30 days
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* probiotic or prebiotic treatments
* concomitant inflammatory intestinal diseases
* pregnancy
* neoplastic diseases
* allergy to milk protein (Alpha-lactalbumin)
* substance abuse
25 Years
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Lo.Li.Pharma s.r.l
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centro Polispecialistico Giovanni Paolo I°
Viterbo, Rome, Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PREBIO_LAC22
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.